Testing effectiveness (Phase 2)Study completedNCT05562934
What this trial is testing
An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients.
Who this might be right for
Resistant Hypertension
Novartis Pharmaceuticals 189